Tamron Hall’s Welcome at the 2020 CRI Virtual Immunotherapy Patient Summit

Tamron Hall welcomes attendees to the first-ever CRI Virtual Immunotherapy Patient Summit. #CRIsummit #Immunotherapy https://www.cancerresearch.org/virtualsummit

We’re delighted to have the one and only Tamron Hall join us as host for our first-ever virtual summit! Tamron and Dr. Jill O’Donnell-Tormey kick off the day with a very warm welcome and overview of what to expect over the course of the two-day event. Jill also shares some of CRI’s history and our impact as the world’s leading nonprofit organization that for more than 65 years has remained dedicated exclusively to harnessing the immune system’s power to cure all cancers.

Tamron Hall is an award-winning TV host, journalist and philanthropist. She is the host and executive producer of the daytime television show “Tamron Hall,” which is produced and distributed in national syndication by Walt Disney Television. For her work on the show’s first season, Tamron won the Daytime Emmy for Outstanding Informative Talk Show Host. “Tamron Hall” was also awarded the prestigious Gracie Award in its first season, which recognizes exemplary programming created by women.

Jill O’Donnell-Tormey, Ph.D., is chief executive officer and director of scientific affairs of the Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that is today the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. She joined the organization in 1987 and has been chief executive since 1993. Prior to joining CRI, she served as a research associate in the Department of Medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University. https://www.cancerresearch.org/about-cri/staff/ceo/jill-o-donnell-tormey-phd

The 2020 CRI Virtual Immunotherapy Patient Summit is part of the Cancer Research Institute's Answer to Cancer Patient Education Program.

Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

Видео Tamron Hall’s Welcome at the 2020 CRI Virtual Immunotherapy Patient Summit канала Cancer Research Institute